Content deleted Content added
m refs using AWB |
open label trials can still be randomized. ex <ref>https://www.ncbi.nlm.nih.gov/pubmed/23385648<ref> |
||
Line 8:
Random assignment, [[blind experiment|blinding]], and [[scientific control|controlling]] are key aspects of the [[design of experiments]], because they help ensure that the results are not spurious or deceptive via [[confounding]]. This is why [[randomized controlled trial]]s are vital in [[clinical research]], especially ones that can be [[double-blinded]] and [[placebo-controlled]].
Mathematically, there are distinctions between randomization, [[pseudorandomness|pseudorandomization]], and [[low-discrepancy sequence|quasirandomization]], as well as between [[random number generation|random number generators]] and [[pseudorandom number generator]]s. How much these differences matter in experiments (such as [[clinical trial]]s) is a matter of [[design of experiments|trial design]] and [[statistics|statistical]] rigor, which affect [[levels of evidence|evidence grading]]. Studies
==Benefits of random assignment==
|